title: Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome.
authors.forename: M
authors.initials: M
authors.lastname: Hummel
authors.forename: D
authors.initials: D
authors.lastname: Buchheidt
authors.forename: S
authors.initials: S
authors.lastname: Reiter
authors.forename: J
authors.initials: J
authors.lastname: Bergmann
authors.forename: R
authors.initials: R
authors.lastname: Hofheinz
authors.forename: R
authors.initials: R
authors.lastname: Hehlmann
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy* / Q000209:etiology; D015448:Leukemia, B-Cell / Q000150:complications*; D007951:Leukemia, Myeloid / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications; D011994:Recombinant Proteins / Q000627:therapeutic use; D014503:Urate Oxidase / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; C469709:rasburicase; D014503:Urate Oxidase